PROFOUND MEDICAL CORP. (PROF) ROI
- 2026-06-30: ROI -55.67%.
- 2026-03-31: ROI -56.85%.
- 2025-09-30: ROI -95.72%.
- 2024-12-31: ROI -42.74%.
Complete source-backed roi history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -55.67% |
| 2026-03-31 | -56.85% |
| 2025-09-30 | -95.72% |
| 2024-12-31 | -42.74% |
Annual ROI
| Date | ROI |
|---|---|
| 2024-12-31 | -42.74% |
| 2023-12-31 | -73.90% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |